rstar, I hope you're right. I've accumulated a crap ton of AUSAF shares at this point, and my average is substantially higher than the present PPS, so I will be a very very happy camper if this thing bounces back to around a buck!
What do we know about ACB’s involvement with all this. It has been an offshoot publicly stated when they went public sept 2018. Is ACB connected to follium? Why are they not mentioned in any of this? Or is this a quiet move by ACB to enter non THC, CBD market in the states?